by Kevin Robb | Nov 9, 2023
BlueRock Therapeutics has generated considerable media buzz with their announcement of positive Phase I clinical trial data on bemdaneprocel (BRT-DA01), an investigational, stem cell-derived, dopaminergic therapy for Parkinson’s disease. The trial is the result of...
by Kevin Robb | Oct 14, 2022
My heart is pounding, and my islets are secreting. Maybe it’s my fifth cup of sugary coffee kicking in, or maybe they’ve been inspired by the plenary session I’m recalling. While the former is more likely, I toy with the idea of the latter. In the “Clinical...
by Krystal Jacques | Jul 28, 2022
I was telling a friend about how sex determination could be an interesting topic for my next blog and he responded asking, “Don’t we already know everything about sex determination?” So I asked an expert: Dr. Robin Lovell-Badge, the Principal Investigator of a stem...
by Sara M. Nolte | Apr 28, 2022
If I were to ask you to think of a genetic disease that should be a priority for gene therapy research, you might say breast cancer, Huntington’s, or cystic fibrosis. And these are all great candidates. But I’d say you’re missing a big one. Sickle cell disease (SCD)...
Comments